PR Newswire
NEW YORK , July 17, 2023 /PRNewswire/ -- Attention Bausch Health Companies Inc. ("Bausch Health") (NYSE: BHC) shareholders:
The Law Offices of Vincent Wong announce that an investigation has commenced into Bausch Health and certain of its officers and directors regarding potential securities fraud . The investigation concerns, in part, the below:
The investigation focuses on whether Bausch Health issued false and/or misleading statements and/or failed to disclose information pertinent to investors concerning its 2022 earnings and guidance and its patent dispute over Xifaxan. On May 10, 2022 , Bausch Health announced its first-quarter 2022 results, prompting the stock price to fall $3.50 per share. Analysts attributed the decline to concerns around the Company's spin-off of Bausch + Lomb Corporation, high debt levels, and anticipation over the Xifaxan patent decision. On July 28, 2022 , the Company issued an update on the Xifaxan patent dispute case between Bausch Health and Norwich . In response to this news, market analysts downgraded Bausch Health and its stock price fell an additional $3.58 per share, representing a decline of more than 50% from its trading price just two months earlier.
If you suffered a loss on your investment in Bausch Health, contact us about potential recovery by using the link below. There is no cost or obligation to you.
https://www.wongesq.com/pslra-1/bausch-health-class-action-submission-form?prid=42153&wire=4
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
E-Mail: vw@wongesq.com
SOURCE The Law Offices of Vincent Wong